You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 22, 28 November 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (92)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Nicotine Nasal Spray on Smoking Cessation

A Randomized, Placebo-Controlled, Double-blind Study

Agneta Hjalmarson, PhD; Mikael Franzon, PhD; Ake Westin, MSc; Olov Wiklund, MD

Arch Intern Med. 1994;154(22):2567-2572.


Abstract

Background
Nicotine replacement therapies have proved to be of value in smoking cessation. However, not all smokers can use the nicotine gum or nicotine patch owing to side effects. In addition, the absorption of nicotine from these formulas is slow compared with smoking. A nicotine nasal spray delivers nicotine more rapidly. The objective of this study was to evaluate the efficacy and safety of the nicotine nasal spray for smoking cessation.

Methods
Subjects were recruited through advertisements in newspapers and among patients referred to the smoking cessation clinic at Sahlgren's Hospital, Göteborg, Sweden. Two hundred forty-eight smokers were treated in small groups with eight counseling sessions over 6 weeks. At their first group session, subjects were randomized to a group receiving nicotine spray (n=125), 0.5 mg of nicotine per single spray, or to a placebo group (n=123). The procedure was double blind. Success rates were measured up to 12 months. The nonsmoking status was verified by expired carbon monoxide less than 10 ppm.

Results
Significantly more subjects in the nicotine group were continuously abstinent for 12 months than in the placebo group (27% vs 15%; odds ratio, 2.16; 95% confidence interval, 1.15 to 4.12). Ten of the 34 abstinent subjects in the nicotine group used the spray for 1 year. Mild or moderate side effects were rather frequent for both sprays, but they were significantly more for the nicotine spray. Subjects with high scores (>7) on Fagerström's tolerance questionnaire had a significantly lower success rate with placebo than with the nicotine spray. For subjects with low scores, there was no difference. Conclusion: Nicotine nasal spray in combination with group treatment is an effective aid to smoking cessation.

(Arch Intern Med. 1994;154:2567-2572)



Author Affiliations

From the Department of Heart and Lung Disease, University of Göteborg, Sweden (Drs Hjalmarson and Wiklund); and Kabi Pharmacia, Piscataway, NJ (Dr Franzon), and Helsingborg, Sweden (Mr Westin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Successful Tobacco Dependence Treatment in Schizophrenia
Williams and Foulds
Am. J. Psychiatry 2007;164:222-227.
FULL TEXT  

A Randomized Controlled Trial of Financial Incentives for Smoking Cessation
Volpp et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:12-18.
ABSTRACT | FULL TEXT  

Treating Tobacco Dependence: State of the Science and New Directions
Lerman et al.
JCO 2005;23:311-323.
ABSTRACT | FULL TEXT  

Individualizing Nicotine Replacement Therapy for the Treatment of Tobacco Dependence: A Randomized Trial
Lerman et al.
ANN INTERN MED 2004;140:426-433.
ABSTRACT | FULL TEXT  

Nicotine replacement therapy in smoking cessation
Campbell
Thorax 2003;58:464-465.
FULL TEXT  

Pharmacologic Therapy for Nicotine Addiction
DeGraff
Chest 2002;122:392-394.
FULL TEXT  

Smoking Cessation
Rennard and Daughton
Chest 2000;117 :360S-364S.
ABSTRACT | FULL TEXT  

New Developments in Smoking Cessation
Prochazka
Chest 2000;117 :169S-175S.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Smoking Cessation
Okuyemi et al.
Arch Fam Med 2000;9:270-281.
ABSTRACT | FULL TEXT  

Recent Advances in the Pharmacotherapy of Smoking
Hughes et al.
JAMA 1999;281:72-76.
ABSTRACT | FULL TEXT  

Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies
Shaw et al.
Tobacco Control 1998;7:161-167.
ABSTRACT | FULL TEXT  

Cigarette smoking prevalence, cessation and relapse
Stapleton
Stat Methods Med Res 1998;7:187-203.
ABSTRACT  

Active Immunization Alters the Plasma Nicotine Concentration in Rats
Hieda et al.
J. Pharmacol. Exp. Ther. 1997;283:1076-1081.
ABSTRACT | FULL TEXT  

The Nicotine Inhaler in Smoking Cessation
Hjalmarson et al.
Arch Intern Med 1997;157:1721-1728.
ABSTRACT  

Nicotine Nasal Spray Works
JWatch Psychiatry 1995;1995:17-17.
FULL TEXT  

NICOTINE NASAL SPRAY WORKS
JWatch General 1994;1994:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.